TNF abrogates the response of the CT.4S cell line to IL-4.
暂无分享,去创建一个
[1] C A Smith,et al. Soluble tumor necrosis factor (TNF) receptors are effective therapeutic agents in lethal endotoxemia and function simultaneously as both TNF carriers and TNF antagonists. , 1993, Journal of immunology.
[2] B. Foxwell,et al. The murine T cell line CT6 provides a novel bioassay for interleukin‐7 , 1993, European journal of immunology.
[3] R. Burger,et al. Responsiveness of the interleukin (IL)-6-dependent cell line B9 to IL-11. , 1993, Journal of immunological methods.
[4] S. Ho,et al. Regulatory effects of transforming growth factor-beta on IL-2- and IL-4-dependent T cell-cycle progression. , 1990, Journal of Immunology.
[5] R. Schreiber,et al. Generation and characterization of hamster monoclonal antibodies that neutralize murine tumor necrosis factors. , 1989, Journal of immunology.
[6] W. Paul,et al. Derivation of a T cell line that is highly responsive to IL-4 and IL-2 (CT.4R) and of an IL-2 hyporesponsive mutant of that line (CT.4S). , 1989, Journal of immunology.
[7] J. Watson. Continuous proliferation of murine antigen-specific helper T lymphocytes in culture , 1979, The Journal of experimental medicine.
[8] K. Smith,et al. Monoclonal cytolytic T-cell lines , 1979, The Journal of experimental medicine.